1. Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy. Issue 8 (3rd July 2022) Authors: Karantanos, Theodoros; Tsai, Hua-Ling; Gondek, Lukasz P.; DeZern, Amy E.; Ghiaur, Gabriel; Dalton, W. Brian; Gojo, Ivana; Prince, Gabrielle T.; Webster, Jonathan; Ambinder, Alexander; Smith, B. Douglas; Levis, Mark J.; Varadhan, Ravi; Jones, Richard J.; Jain, Tania Journal: Leukemia & lymphoma Issue: Volume 63:Issue 8(2022) Page Start: 1942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The metabolic reprogramming and vulnerability of SF3B1 mutations. (3rd May 2020) Authors: Dalton, W. Brian Journal: Molecular & cellular oncology Issue: Volume 7:Number 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗